HYPR
Hyperfine IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$147.91M
P/E Ratio
—
EPS
$-0.40
Beta
1.42
52W High
$2.22
52W Low
$0.54
50-Day MA
$1.36
200-Day MA
$1.25
Dividend Yield
—
Profit Margin
-226.90%
Forward P/E
—
PEG Ratio
—
About Hyperfine Inc
Hyperfine Inc. is a pioneering medical technology company recognized for its groundbreaking development of the first FDA-cleared portable MRI system, which significantly improves access to imaging directly at the point of care. This innovation not only enhances patient care but also streamlines clinical decision-making, catering to the urgent need for efficient and accessible diagnostic solutions in today’s healthcare environment. With a strong emphasis on cost efficiency and patient convenience, Hyperfine is strategically positioned to capture market opportunities, representing an attractive investment for institutional investors focused on transformative advancements in healthcare.
Fundamentals
| Revenue (TTM) | $15.33M |
| Gross Profit (TTM) | $7.85M |
| EBITDA | $-33.61M |
| Operating Margin | -219.30% |
| Return on Equity | -89.80% |
| Return on Assets | -38.20% |
| Revenue/Share (TTM) | $0.18 |
| Book Value | $0.35 |
| Price-to-Book | 4.30 |
| Price-to-Sales (TTM) | 9.65 |
| EV/Revenue | 7.86 |
| EV/EBITDA | -0.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 82.60% |
| Shares Outstanding | $84.22M |
| Float | $80.04M |
| % Insiders | 4.83% |
| % Institutions | 14.67% |
Historical Volatility
HV 10-Day
66.37%
HV 20-Day
93.94%
HV 30-Day
77.87%
HV 60-Day
70.71%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($2.17 target)
3
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026